The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 13, 2026 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 2K | $29.83 | $54K |
| Jan 12, 2026 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 3K | $27.54 | $80K |
| Dec 31, 2025 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 4K | $21.36 | $92K |
| Dec 30, 2025 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 3K | $21.73 | $63K |
| Dec 18, 2025 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 4K | $12.62 | $52K |
| Nov 25, 2025 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 5K | $8.37 | $39K |
| Nov 13, 2025 | Patel Snehal | CEO and CFO, Director, 10% Owner | Grant(A) | 100K | — | $0 |
| Nov 7, 2025 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 11K | $8.43 | $89K |
| Oct 31, 2025 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 2K | $9.26 | $21K |
| Apr 25, 2025 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 4K | $9.88 | $36K |
| Apr 17, 2025 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 5K | $8.98 | $48K |
| Apr 7, 2025 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 4K | $9.10 | $33K |
| Apr 4, 2025 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 6K | $8.73 | $48K |
| Jan 10, 2025 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 3K | $12.51 | $31K |
| Jan 7, 2025 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 2K | $13.75 | $25K |
| Jan 6, 2025 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 1K | $13.31 | $15K |
| Jan 3, 2025 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 3K | $12.95 | $44K |
| Jan 2, 2025 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 2K | $11.97 | $24K |
| Dec 31, 2024 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 2K | $11.36 | $27K |
| Dec 30, 2024 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 3K | $11.12 | $36K |
| Dec 24, 2024 | Rothe Eric | Director | Grant(A) | 41K | — | $0 |
| Dec 24, 2024 | Daugherty Frank Joseph | Chief Medical Officer, Director | Grant(A) | 105K | — | $0 |
| Dec 24, 2024 | Hallock Kenneth | Director | Grant(A) | 41K | — | $0 |
| Dec 24, 2024 | Thompson Jaye | VP Clinical Reg Affairs | Grant(A) | 150K | — | $0 |
| Dec 24, 2024 | McWilliams David | Director | Grant(A) | 62K | — | $0 |
| Dec 24, 2024 | Patel Snehal | CEO and CFO, Director, 10% Owner | Grant(A) | 25K | — | $0 |
| Dec 24, 2024 | Patel Snehal | CEO and CFO, Director, 10% Owner | Grant(A) | 1.1M | — | $0 |
| Nov 21, 2024 | Thompson Jaye | VP Clinical Reg Affairs | Buy(P) | 1K | $12.91 | $13K |
| Sep 26, 2024 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 2K | $14.63 | $22K |
| Aug 12, 2024 | Thompson Jaye | VP Clinical Reg Affairs | Buy(P) | 800 | $13.85 | $11K |
| Aug 6, 2024 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 2K | $13.81 | $28K |
| Aug 5, 2024 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 6K | $13.18 | $72K |
| Aug 2, 2024 | Thompson Jaye | VP Clinical Reg Affairs | Buy(P) | 1K | $15.15 | $15K |
| Jul 23, 2024 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 2K | $15.89 | $24K |
| Jul 18, 2024 | Thompson Jaye | VP Clinical Reg Affairs | Buy(P) | 1K | $16.00 | $16K |
| Jun 13, 2024 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 175K | $14.30 | $2.5M |
| Apr 1, 2024 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 3K | $19.08 | $57K |
| Mar 22, 2024 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 3K | $19.98 | $50K |
| Mar 20, 2024 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 2K | $17.68 | $27K |
| Mar 5, 2024 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 4K | $12.49 | $44K |
| Mar 4, 2024 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 4K | $13.03 | $53K |
| Feb 16, 2024 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 11K | $11.16 | $121K |
| Feb 15, 2024 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 13K | $11.07 | $141K |
| Nov 10, 2023 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 5K | $10.17 | $51K |
| Nov 3, 2023 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 4K | $9.11 | $32K |
| Oct 27, 2023 | Thompson Jaye | VP Clinical Reg Affairs | Buy(P) | 500 | $8.57 | $4K |
| Oct 26, 2023 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 3K | $7.97 | $20K |
| Oct 25, 2023 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 3K | $7.91 | $20K |
| Oct 10, 2023 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 1K | $9.07 | $9K |
| Oct 4, 2023 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 2K | $8.63 | $17K |
| Sep 26, 2023 | Thompson Jaye | VP Clinical Reg Affairs | Buy(P) | 600 | $8.71 | $5K |
| Sep 19, 2023 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 4K | $8.95 | $36K |
| Sep 11, 2023 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 1K | $9.48 | $9K |
| Aug 22, 2023 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 1K | $9.97 | $10K |
| Aug 4, 2023 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 2K | $10.55 | $21K |
| Jul 21, 2023 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 1K | $9.20 | $9K |
| Jul 13, 2023 | Thompson Jaye | VP Clinical Reg Affairs | Buy(P) | 250 | $9.49 | $2K |
| May 17, 2023 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 1K | $11.69 | $12K |
| Apr 28, 2023 | Thompson Jaye | VP Clinical Reg Affairs | Buy(P) | 250 | $11.22 | $3K |
| Apr 19, 2023 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 7K | $11.10 | $78K |
| Apr 18, 2023 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 2K | $11.12 | $22K |
| Apr 11, 2023 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 5K | $12.42 | $62K |
| Apr 11, 2023 | Thompson Jaye | VP Clinical Reg Affairs | Buy(P) | 1K | $11.87 | $12K |
| Mar 15, 2023 | Thompson Jaye | VP Clinical Reg Affairs | Buy(P) | 250 | $12.71 | $3K |
| Mar 10, 2023 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 1K | $12.12 | $12K |
| Feb 24, 2023 | Thompson Jaye | VP Clinical Reg Affairs | Buy(P) | 250 | $15.40 | $4K |
| Feb 17, 2023 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 600 | $16.53 | $10K |
| Feb 10, 2023 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 1K | $18.68 | $19K |
| Feb 3, 2023 | Thompson Jaye | VP Clinical Reg Affairs | Buy(P) | 250 | $20.84 | $5K |
| Jan 27, 2023 | Thompson Jaye | VP Clinical Reg Affairs | Buy(P) | 250 | $19.20 | $5K |
| Jan 27, 2023 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 2K | $19.35 | $39K |
| Jan 20, 2023 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 2K | $17.37 | $26K |
| Jan 13, 2023 | Thompson Jaye | VP Clinical Reg Affairs | Buy(P) | 250 | $16.50 | $4K |
| Jan 6, 2023 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 2K | $15.18 | $23K |
| Dec 29, 2022 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 4K | $15.19 | $61K |
| Dec 16, 2022 | Thompson Jaye | VP Clinical Reg Affairs | Buy(P) | 250 | $12.94 | $3K |
| Dec 16, 2022 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 1K | $13.01 | $13K |
| Dec 9, 2022 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 2K | $13.11 | $26K |
| Dec 2, 2022 | Thompson Jaye | VP Clinical Reg Affairs | Buy(P) | 250 | $13.98 | $3K |
| Dec 2, 2022 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 1K | $13.84 | $14K |
| Nov 2, 2022 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 2K | $8.79 | $18K |
| Oct 14, 2022 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 3K | $9.75 | $29K |
| Oct 7, 2022 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 2K | $9.72 | $19K |
| Sep 30, 2022 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 1K | $9.46 | $9K |
| Sep 29, 2022 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 1K | $9.23 | $9K |
| Jun 24, 2022 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 23K | $9.13 | $206K |
| Jun 24, 2022 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 6K | $9.13 | $59K |
| Jun 22, 2022 | McWilliams David | Director | Grant(A) | 62K | — | $0 |
| Jun 22, 2022 | Rothe Eric | Director | Grant(A) | 41K | — | $0 |
| Jun 22, 2022 | Hallock Kenneth | Director | Grant(A) | 41K | — | $0 |
| Jun 22, 2022 | Thompson Jaye | VP Clinical Reg Affairs | Grant(A) | 150K | — | $0 |
| Jun 22, 2022 | Patel Snehal | CEO and CFO, Director, 10% Owner | Grant(A) | 1.0M | — | $0 |
| Jun 22, 2022 | Patel Snehal | CEO and CFO, Director, 10% Owner | Grant(A) | 25K | — | $0 |
| Jun 22, 2022 | Daugherty Frank Joseph | Chief Medical Officer, Director | Grant(A) | 105K | — | $0 |
| Jun 16, 2022 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 8K | $7.13 | $57K |
| Jun 14, 2022 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 12K | $7.91 | $95K |
| Jun 10, 2022 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 12K | $8.33 | $100K |
| Jun 9, 2022 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 5K | $10.90 | $49K |
| Jun 7, 2022 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 6K | $8.55 | $51K |
| Jun 3, 2022 | Patel Snehal | CEO and CFO, Director, 10% Owner | Buy(P) | 9K | $8.35 | $77K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).